Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer.
about
Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancerA reference set of health utilities for long-term survivors of prostate cancer: population-based data from Ontario, Canada.Impact of treatment planning and delivery factors on gastrointestinal toxicity: an analysis of data from the RADAR prostate radiotherapy trial.Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer.Prospective evaluation of a hydrogel spacer for rectal separation in dose-escalated intensity-modulated radiotherapy for clinically localized prostate cancer.Effects of prostate-rectum separation on rectal dose from external beam radiotherapy.The impact of financial interest in intensity-modulated radiation therapy on the utilization of radiation therapy for treatment of newly diagnosed prostate cancer: a single center experienceIn-phantom dose verification of prostate IMRT and VMAT deliveries using plastic scintillation detectors.Urinary adverse effects of pelvic radiotherapy.Feasibility and radiation induced toxicity regarding the first application of transperineal implementation of biocompatible balloon for high dose radiotherapy in patients with prostate carcinomaEstimating the costs of intensity-modulated and 3-dimensional conformal radiotherapy in Ontario.Toxicity and Long-Term Outcomes of Dose-Escalated Intensity Modulated Radiation Therapy to 74Gy for Localised Prostate Cancer in a Single Australian Centre.The benefit of using bladder sub-volume equivalent uniform dose constraints in prostate intensity-modulated radiotherapy planning.Dosimetric comparison between IMRT delivery modes: Step-and-shoot, sliding window, and volumetric modulated arc therapy - for whole pelvis radiation therapy of intermediate-to-high risk prostate adenocarcinomaTreating prostate cancer with radiotherapy."Pelvic radiation disease": new understanding and new solutions for a new disease in the era of cancer survivorship.Choline PET based dose-painting in prostate cancer--modelling of dose effects78Gy with Fiducial Marker Image-Guided Radiotherapy in Prostate Cancer: Single Center Analysis of 301 Patients.Spacer application for prostate cancer radiation therapy.[External beam radiotherapy in the treatment of prostate cancer].A comparison of clinical outcomes between three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer.Image guided dose escalated prostate radiotherapy: still room to improve.Intensity-modulated radiotherapy reduces toxicity with similar biochemical control compared with 3-dimensional conformal radiotherapy for prostate cancer: A randomized clinical trial.A treatment planning study comparing tomotherapy, volumetric modulated arc therapy, Sliding Window and proton therapy for low-risk prostate carcinomaIntensity Modulated Radiation Therapy Reduces Gastrointestinal Toxicity in Patients Treated with Androgen Deprivation Therapy for Prostate Cancer.A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomes.The importance of combined radiation and endocrine therapy in locally advanced prostate cancer.Three Years of Salvage IMRT for Prostate Cancer: Results of the Montpellier Cancer Center3 Tesla multiparametric MRI for GTV-definition of Dominant Intraprostatic Lesions in patients with Prostate Cancer--an interobserver variability study.[Radiation therapy for prostate cancer in the new S3 guideline. Part 1: localized and locally advanced prostate cancer].Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer.Prostate and seminal vesicle volume based consideration of prostate cancer patients for treatment with 3D-conformal or intensity-modulated radiation therapy.[Use of hydrogel as spacer in Denovier's space: optimization of IMRT radiotherapy of localized prostate cancer].The German S3 guideline prostate cancer: aspects for the radiation oncologist.Does Certificate of Need Minimize Intensity Modulated Radiation Therapy Use in Patients with Low Risk Prostate Cancer?Adding intensity-modulated radiotherapy to the pelvis does not worsen the adverse effect profiles compared to limited field radiotherapy in men with prostate cancer at 12-month follow-up.Can a peri-rectal hydrogel spaceOAR programme for prostate cancer intensity-modulated radiotherapy be successfully implemented in a regional setting?Evaluation of techniques for slice sensitivity profile measurement and analysis.Simultaneous integrated vs. sequential boost in VMAT radiotherapy of high-grade gliomas.Treatment of prostate cancer with intensity modulated radiation therapy (IMRT).
P2860
Q28252307-8E09A225-97A7-43D9-89AC-1AD032B87E55Q30613075-2C2D2142-234A-4C24-B54D-B1965973AE5EQ30877686-D1298D64-7E34-491F-9A94-05C0D8F89C7EQ34268907-C8B018E0-4D30-4BF5-A8B1-40001B54FD1BQ34556112-CB72BA88-9F0E-4A08-ADE1-90718A2E4DA3Q35047440-6853C689-89E0-47F8-9E7B-0F5BB041AE0EQ35898128-36F12488-4890-4249-90DF-5B68E97D9F02Q36410345-6396929C-BCF4-49F8-AA1D-EA92F4BBD8A3Q36450629-C3EAE720-4525-4DA8-93DF-3D4BFFD34D7AQ36921562-DA2FD850-0980-460E-97B2-07B103777262Q36989128-A7807586-8DB1-4001-8950-22CD8F54E8D6Q37137423-E8F0F904-3E01-4C98-886D-8F5008C7107EQ37510070-FAF814E0-0BFE-4563-92EB-27F830B6583AQ37645821-40852309-9F4C-4FFF-A167-1B5C65FF4528Q37780448-EE58F6C3-88F8-4E90-B2E2-29FF0A930B24Q37824328-0686CF90-4BF9-46CE-8643-41840F2ABFADQ38445916-CE439634-9A4D-418D-9B2A-6599D62F6A25Q39013203-9C10EC5D-B006-4878-9C6C-EEEAC937955BQ39198013-99983BAD-61F5-4FBA-A6A6-48F07EDBBAAAQ39239309-FA751BAB-A987-4BE3-8DEE-3294127537C8Q39252193-575C4CC5-3CF4-46E1-A434-BC65ADC27587Q39932645-C88CDB6F-64BE-4870-8AF0-7CF4252BD4AAQ40827296-03C5D16F-DCC7-4AD5-A955-DB33A1DB063BQ41190542-9728937A-4ED5-494D-A36C-1469520E778CQ41841932-BA7F0C81-C4C9-4A3D-AC3D-44A51558DA3CQ42116748-B672357C-AF16-4EDE-9FB8-51899D2B5393Q42140746-1E6FFBB7-8C2E-4BC3-92E0-0E595F5D7C2FQ42539752-1476D24C-9F43-4897-A59C-F7B6EB883FDDQ42906342-C009B688-D8F4-4D52-8F81-FAF8A35DCA03Q43794655-D601882F-2590-4688-8943-BE9781436E01Q45213721-293D6AD2-527F-484B-8AFC-D4018A879869Q45936840-58E3C742-1F3C-4C9C-9465-1F90C041CE1CQ46149480-5E0B8362-F7BD-471F-8DEC-069F3C7138A8Q46765601-C2BA61A8-880C-49D4-941A-90993EB7B86FQ47103552-6F475425-5AC3-44D4-BEB9-BCF448A7E38BQ48075929-B433CDF0-5936-4319-A5EC-A6510F8888C9Q50917060-1D704284-FF7C-4562-8EA7-1796B1705109Q51095886-6F9779E7-8E30-4BB6-A746-E081FBF01527Q52149946-678890AC-7140-4080-8DF4-E7041AD9DA03Q53531406-E775B2AD-60BB-4396-81D6-55CA4BC19C9E
P2860
Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Role of intensity-modulated ra ...... for localized prostate cancer.
@ast
Role of intensity-modulated ra ...... for localized prostate cancer.
@en
type
label
Role of intensity-modulated ra ...... for localized prostate cancer.
@ast
Role of intensity-modulated ra ...... for localized prostate cancer.
@en
prefLabel
Role of intensity-modulated ra ...... for localized prostate cancer.
@ast
Role of intensity-modulated ra ...... for localized prostate cancer.
@en
P2093
P1476
Role of intensity-modulated ra ...... for localized prostate cancer.
@en
P2093
Abrahim Al-Mamgani
Joos V Lebesque
Stephanie T H Peeters
Wilma D Heemsbergen
P304
P356
10.1016/J.IJROBP.2008.04.063
P407
P577
2008-08-19T00:00:00Z